Oncology Diagnostics Panel Session

Kineticos recently hosted a panel with 3 industry veterans to gain insight regarding the nuances of the oncology diagnostics market.  This third installment of the series discusses how the emergence of Immuno-Oncology has changed the Oncology Diagnostics landscape.

Panel Members

  • Eric Mayer, CEO, EDP Biotech
  • Sandra Dunn, CEO, Phoenix Molecular
  • Brian Kelly, Global Director, Diagnostic Partnering, Thermo Fisher

Click here for a condensed and edited version of Part 3.